BioXcel Therapeutics BTAIQ Balance Sheet (2017-2026)

OTC BTAIQ
$0.05 +0.01 (+25.00%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

BioXcel Therapeutics Quarterly Balance Sheet

Periods 35 quarters
Latest Jun 2026

BioXcel Therapeutics reported total assets of $28.80M and total liabilities of $144.26M for the quarter ended Jun 2026, up 11.7% year over year. This balance sheet covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
0.53M0.60M0.68M0.76M0.85M0.89M0.96M1.04M1.11M1.19M1.27M1.35M1.43M1.50M1.58M1.65M1.73M1.80M1.86M1.88M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
252.91M232.97M200.44M233.45M232.31M193.72M165.52M127.55M89.96M65.22M74.14M56.27M40.39M29.85M31.01M17.43M36.18M28.41M17.18M12.84M
Receivables - NetNet Receivables
0.25M0.28M0.43M0.73M0.07M0.38M0.81M0.00M0.13M0.02M0.23M0.22M0.08M
Receivables - OtherOther Receivables
Receivables
0.25M0.28M0.43M0.73M0.07M0.38M0.81M0.00M0.13M0.02M0.23M0.22M0.08M
Raw Materials
0.69M0.68M0.68M0.68M0.68M0.68M0.94M0.94M0.84M0.83M0.51M0.46M0.43M0.39M0.32M0.41M0.41M
Work In Process
0.40M0.12M0.71M0.60M0.65M0.25M0.39M0.37M
Finished Goods
0.30M0.60M0.59M1.27M1.24M0.73M0.41M1.25M1.45M0.69M0.17M0.18M0.07M0.07M0.04M0.09M0.07M
Inventory
0.68M1.40M1.41M1.99M1.95M1.93M2.02M1.99M2.44M2.68M1.52M0.68M0.64M0.51M0.46M0.72M0.50M0.48M
Prepaid Assets
4.02M2.89M4.97M8.38M5.51M3.07M4.51M3.70M3.85M2.78M2.10M2.77M4.48M5.29M4.74M5.15M5.69M4.03M3.94M3.07M
Current Assets
256.93M236.81M207.56M244.92M241.66M202.87M177.27M138.24M98.74M72.14M80.92M64.18M47.79M37.39M37.78M25.24M44.40M44.69M33.91M28.70M
Non-Current Assets
Property, Plant & Equipment (Net)
1.34M1.29M1.34M1.27M1.19M1.08M1.00M0.94M0.86M0.78M0.71M0.63M0.55M0.47M0.40M0.32M0.25M0.17M0.12M0.10M
Other Non-Current Assets
1.75M0.09M0.96M0.93M0.93M0.93M0.93M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M
Non-Current Assets
4.40M2.63M3.48M3.31M3.16M2.98M2.83M1.86M1.71M1.56M1.41M1.25M1.10M0.94M0.79M0.55M0.39M0.23M0.12M0.10M
Assets
261.33M239.44M211.04M248.24M244.82M205.85M180.10M140.10M100.45M73.70M82.32M65.44M48.89M38.34M38.57M25.79M44.79M44.92M34.02M28.80M
Liabilities
Current Liabilities
Accounts Payables
3.44M4.68M5.07M6.02M5.87M10.23M7.74M11.20M10.67M13.65M17.22M13.26M14.89M15.99M15.45M16.69M16.28M14.70M16.25M18.78M
Notes Payables
Payables
3.44M4.68M5.07M6.02M5.87M10.23M7.74M11.20M10.67M13.65M17.22M13.26M14.89M15.99M15.45M16.69M16.28M14.70M16.25M18.78M
Accumulated Expenses
10.72M11.49M10.58M13.37M13.95M18.67M17.07M19.13M26.61M12.42M13.68M13.48M10.19M5.76M3.99M5.09M4.36M4.34M6.39M3.92M
Other Accumulated Expenses
0.29M0.29M0.30M0.31M2.90M3.17M3.09M3.11M0.83M0.74M0.33M0.34M0.25M0.32M0.42M0.37M0.45M0.62M2.35M0.56M
Short term Debt
5.61M11.22M16.82M24.93M22.43M104.45M
Current Taxes
0.20M0.30M0.37M0.26M0.53M0.08M0.21M0.14M0.13M0.12M0.09M0.07M0.07M0.09M0.07M0.11M0.10M0.03M0.05M0.04M
Total Current Liabilities
14.60M16.67M16.00M20.00M23.38M32.90M28.76M34.74M39.41M27.27M31.48M27.29M25.56M22.23M25.55M33.38M37.80M53.93M54.99M137.15M
Non-Current Liabilities
Non-Current Debt
61.08M91.69M93.05M95.06M96.85M99.09M100.60M101.63M103.01M104.44M102.51M99.92M97.47M92.30M84.66M77.86M
Operating Leases
1.18M1.10M1.03M0.95M0.87M0.79M0.70M0.62M0.53M0.44M0.35M0.26M0.16M0.07M
Other Non-Current Liabilities
1.95M1.89M2.34M2.57M2.03M2.03M1.91M21.22M9.19M4.37M6.63M3.27M2.61M3.60M1.79M6.72M7.11M
Total Non-Current Liabilities
82.02M115.94M126.73M124.52M132.21M139.03M128.31M133.46M130.55M130.16M124.81M125.46M130.84M130.11M138.59M132.85M137.15M
Total Liabilities
15.78M17.77M17.02M83.97M117.83M129.08M127.10M134.23M141.06M130.21M154.69M139.74M134.53M131.44M128.74M133.46M133.71M140.38M139.57M144.26M
Shareholder's Equity
Total Debt
61.08M91.69M93.05M95.06M96.85M99.09M100.60M101.63M103.01M104.44M102.51M105.53M108.69M109.12M109.59M100.29M104.45M
Common Equity
245.56M221.67M194.02M164.26M126.99M76.78M53.01M5.86M-40.61M-56.51M-72.36M-74.30M-85.63M-93.10M-90.17M-107.67M-88.92M-95.46M-105.54M-115.46M
Liabilities and Shareholders Equity
261.33M239.44M211.04M248.24M244.82M205.85M180.10M140.10M100.45M73.70M82.32M65.44M48.89M38.34M38.57M25.79M44.79M44.92M34.02M28.80M
Retained Earnings
-219.66M-245.79M-277.26M-314.93M-356.74M-411.55M-464.34M-517.86M-568.34M-590.60M-617.39M-625.69M-639.34M-650.20M-657.45M-676.64M-707.55M-720.09M-732.78M-747.50M

BioXcel Therapeutics Balance Sheet API

Pull BioXcel Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BTAIQ&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY